tiprankstipranks
Rallybio (RLYB)
NASDAQ:RLYB
US Market
Holding RLYB?
Track your performance easily

Rallybio (RLYB) Financial Statements

286 Followers

Rallybio Financial Overview

Rallybio's market cap is currently ―. The company's EPS TTM is $-1.589; its P/E ratio is -0.73; Rallybio is scheduled to report earnings on March 18, 2025, and the estimated EPS forecast is $-0.29. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 299.00K$ 299.00K---
Gross Profit$ 299.00K$ 299.00K---
EBIT$ -12.07M$ -17.04M$ -19.79M$ -21.11M$ -19.36M
EBITDA$ -12.38M$ -17.00M$ -19.75M$ -21.08M$ -19.33M
Net Income Common Stockholders$ -11.47M$ -16.24M$ -19.03M$ -20.24M$ -18.37M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 75.14M$ 88.61M$ 94.17M$ 109.93M$ 121.38M
Total Assets$ 79.01M$ 92.43M$ 99.36M$ 115.62M$ 133.19M
Total Debt$ 230.00K$ 284.00K$ 339.00K$ 392.00K$ 428.00K
Net Debt$ -74.91M$ -88.33M$ -93.84M$ -109.54M$ -120.96M
Total Liabilities$ 8.19M$ 12.41M$ 10.20M$ 9.44M$ 9.61M
Stockholders Equity$ 70.82M$ 80.02M$ 89.16M$ 106.18M$ 123.58M
Cash Flow-
Free Cash Flow$ -13.54M$ -10.42M$ -15.46M$ -11.66M$ -16.47M
Operating Cash Flow$ -13.54M$ -10.42M$ -15.46M$ -11.64M$ -16.47M
Investing Cash Flow$ 22.20M$ 2.60M$ 10.26M$ 16.91M$ 3.07M
Financing Cash Flow$ -11.00K$ 5.19M-$ 72.00K-
Currency in USD

Rallybio Earnings and Revenue History

Rallybio Debt to Assets

Rallybio Cash Flow

Rallybio Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis